Treatment of Acute Periprosthetic Total Hip Arthroplasty Infections

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2013-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the success rate of two treatments for infection after total hip replacement: single stage arthroplasty exchange (your surgeon will take out your original implants and replace them with a complete new set) compared to irrigation and debridement with modular exchange (your surgeon will clean your implants with a surgical solution and take out the plastic liner and replace it with a new one - the rest of your hip implants will stay in place). The goal is to see if one is better than the other for the treatment of hip infection after a total hip replacement. A successful treatment means that you did not have to have another surgery on your hip for an infection-related reason.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement

NCT01373099

Osteoarthritis Hip Infection Prosthetic Joint Infection +2 more

COMPLETED NA

One Stage Versus Two Stage For Periprosthetic Hip And Knee Infection

NCT02734134

Surgical Site Infection

ACTIVE_NOT_RECRUITING NA

Evaluation of Conventional Antibiotic Prophylaxis During a Change of Hip or Knee Infected at a Time

NCT02272205

Total Hip Replacement

COMPLETED

Contribution of a Clinical Pathway for the Treatment of Hip Prosthesis Infections

NCT02660268

Hip Prosthesis Infection

COMPLETED NA

One-Stage Exchange for Chronically Infected Total Hip Arthroplasty

NCT02825381

Infection

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periprosthetic Infection Total Hip Arthoplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

open debridement with modular exchange

Group Type ACTIVE_COMPARATOR

open debridement with modular exchange

Intervention Type PROCEDURE

one stage exchange

Group Type ACTIVE_COMPARATOR

one stage exchange

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

open debridement with modular exchange

Intervention Type PROCEDURE

one stage exchange

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Return to the OR for a drainage procedure within six weeks of index primary uncemented arthroplasty 1a) Exam findings within six weeks of index operation:

* Drainage for more than 7 days
* Wound appearance consistent with deep infection or hematoma
* Persistent fever or evidence of bacteremia
* All patients currently deemed appropriate for irrigation and debridement
2. Labs

\- Rising inflammatory seromarkers
3. Aspiration with a positive culture

Exclusion Criteria

1. Previous history of periprosthetic infection
2. Prisoners
3. Patients not willing to consent for the proposed treatment
4. Patients with altered mental status
5. Concurrent metastatic infection
6. Superficial Infection

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No